(JBSS) John Sanfilippo & Son - Overview
Stock: Nuts, Bars, Butters, Snacks, Toppings
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.82% |
| Yield on Cost 5y | 2.46% |
| Yield CAGR 5y | -12.22% |
| Payout Consistency | 36.3% |
| Payout Ratio | 33.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.8% |
| Relative Tail Risk | -9.87% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.46 |
| Alpha | 9.01 |
| Character TTM | |
|---|---|
| Beta | 0.132 |
| Beta Downside | 0.096 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.74% |
| CAGR/Max DD | -0.05 |
Description: JBSS John Sanfilippo & Son December 25, 2025
John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) processes and distributes a broad portfolio of tree nuts, peanuts, and derived snack products across the United States through its subsidiary JBSS Ventures, LLC. Its catalog spans raw and flavored nuts (e.g., almonds, pecans, cashews), nut-based bars, peanut butter, dried fruit, coated snacks, and specialty items such as sunflower kernels, chickpea snacks, and cheese-flavored baked goods, sold under both proprietary brands (Fisher, Orchard Valley Harvest, Squirrel Brand, Southern Style Nuts, Just the Cheese) and private-label contracts.
The company reaches retailers, wholesalers, and food-service customers via a network of independent brokers, distributors, and contract packaging partners, and it also operates a single retail outlet. Founded in 1922 and headquartered in Elgin, Illinois, JBSS sits in the GICS sub-industry “Packaged Foods & Meats.”
Key recent metrics (FY 2023): net sales of approximately $1.5 billion, adjusted EBITDA margin near 9 %, and a cash conversion cycle of roughly 45 days-both indicating solid operational efficiency but also exposing the business to commodity price swings in almonds and peanuts, which have risen 12 % YoY due to drought-driven supply constraints.
Sector drivers that materially affect JBSS include: (1) the continued consumer shift toward plant-based, protein-rich snacks, which has lifted overall nut consumption by an estimated 4 % CAGR over the past five years; (2) inflationary pressure on discretionary food spending, which can compress margins on premium-priced nut products; and (3) the volatility of agricultural inputs (water, fertilizer) that can impact harvest yields and thus raw-material costs.
For a deeper quantitative view of JBSS’s valuation metrics, you might explore the ValueRay platform’s analyst toolkit.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 70.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 2.11 > 1.0 |
| NWC/Revenue: 16.51% < 20% (prev 14.00%; Δ 2.51% < -1%) |
| CFO/TA 0.17 > 3% & CFO 105.3m > Net Income 70.4m |
| Net Debt (65.5m) to EBITDA (123.5m): 0.53 < 3 |
| Current Ratio: 2.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (11.7m) vs 12m ago 0.21% < -2% |
| Gross Margin: 19.06% > 18% (prev 0.18%; Δ 1888 % > 0.5%) |
| Asset Turnover: 196.6% > 50% (prev 205.2%; Δ -8.53% > 0%) |
| Interest Coverage Ratio: 26.02 > 6 (EBITDA TTM 123.5m / Interest Expense TTM 3.75m) |
Altman Z'' 5.32
| A: 0.31 (Total Current Assets 337.2m - Total Current Liabilities 148.4m) / Total Assets 617.7m |
| B: 0.37 (Retained Earnings 229.0m / Total Assets 617.7m) |
| C: 0.17 (EBIT TTM 97.6m / Avg Total Assets 581.5m) |
| D: 0.93 (Book Value of Equity 229.7m / Total Liabilities 247.6m) |
| Altman-Z'' Score: 5.32 = AAA |
Beneish M -3.35
| DSRI: 0.96 (Receivables 79.8m/81.2m, Revenue 1.14b/1.12b) |
| GMI: 0.93 (GM 19.06% / 17.70%) |
| AQI: 0.69 (AQ_t 0.06 / AQ_t-1 0.09) |
| SGI: 1.02 (Revenue 1.14b / 1.12b) |
| TATA: -0.06 (NI 70.4m - CFO 105.3m) / TA 617.7m) |
| Beneish M-Score: -3.35 (Cap -4..+1) = AA |
What is the price of JBSS shares?
Over the past week, the price has changed by -2.83%, over one month by +12.59%, over three months by +17.18% and over the past year by +14.49%.
Is JBSS a buy, sell or hold?
What are the forecasts/targets for the JBSS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 109 | 38.7% |
| Analysts Target Price | 109 | 38.7% |
| ValueRay Target Price | 80.7 | 2.7% |
JBSS Fundamental Data Overview February 07, 2026
P/E Forward = 15.6495
P/S = 0.8111
P/B = 2.5153
Revenue TTM = 1.14b USD
EBIT TTM = 97.6m USD
EBITDA TTM = 123.5m USD
Long Term Debt = 28.8m USD (from longTermDebt, last quarter)
Short Term Debt = 15.9m USD (from shortTermDebt, last quarter)
Debt = 67.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 65.5m USD (from netDebt column, last quarter)
Enterprise Value = 855.5m USD (790.1m + Debt 67.9m - CCE 2.40m)
Interest Coverage Ratio = 26.02 (Ebit TTM 97.6m / Interest Expense TTM 3.75m)
EV/FCF = 26.11x (Enterprise Value 855.5m / FCF TTM 32.8m)
FCF Yield = 3.83% (FCF TTM 32.8m / Enterprise Value 855.5m)
FCF Margin = 2.87% (FCF TTM 32.8m / Revenue TTM 1.14b)
Net Margin = 6.15% (Net Income TTM 70.4m / Revenue TTM 1.14b)
Gross Margin = 19.06% ((Revenue TTM 1.14b - Cost of Revenue TTM 925.5m) / Revenue TTM)
Gross Margin QoQ = 18.80% (prev 18.11%)
Tobins Q-Ratio = 1.38 (Enterprise Value 855.5m / Total Assets 617.7m)
Interest Expense / Debt = 0.74% (Interest Expense 503.0k / Debt 67.9m)
Taxrate = 26.73% (6.55m / 24.5m)
NOPAT = 71.5m (EBIT 97.6m * (1 - 26.73%))
Current Ratio = 2.27 (Total Current Assets 337.2m / Total Current Liabilities 148.4m)
Debt / Equity = 0.18 (Debt 67.9m / totalStockholderEquity, last quarter 370.1m)
Debt / EBITDA = 0.53 (Net Debt 65.5m / EBITDA 123.5m)
Debt / FCF = 2.00 (Net Debt 65.5m / FCF TTM 32.8m)
Total Stockholder Equity = 360.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.10% (Net Income 70.4m / Total Assets 617.7m)
RoE = 19.54% (Net Income TTM 70.4m / Total Stockholder Equity 360.1m)
RoCE = 25.09% (EBIT 97.6m / Capital Employed (Equity 360.1m + L.T.Debt 28.8m))
RoIC = 16.44% (NOPAT 71.5m / Invested Capital 434.8m)
WACC = 5.94% (E(790.1m)/V(857.9m) * Re(6.40%) + D(67.9m)/V(857.9m) * Rd(0.74%) * (1-Tc(0.27)))
Discount Rate = 6.40% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.29%
[DCF Debug] Terminal Value 81.49% ; FCFF base≈26.6m ; Y1≈18.4m ; Y5≈9.36m
Fair Price DCF = 25.01 (EV 291.7m - Net Debt 65.5m = Equity 226.2m / Shares 9.05m; r=5.94% [WACC]; 5y FCF grow -36.04% → 2.90% )
EPS Correlation: 23.71 | EPS CAGR: 11.41% | SUE: 0.51 | # QB: 0
Revenue Correlation: 71.76 | Revenue CAGR: 10.21% | SUE: 0.00 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.73 | Chg30d=+0.018 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-06-30): EPS=5.94 | Chg30d=+0.428 | Revisions Net=+1 | Growth EPS=+18.0% | Growth Revenue=+0.0%
EPS next Year (2027-06-30): EPS=7.14 | Chg30d=+0.673 | Revisions Net=+1 | Growth EPS=+20.3% | Growth Revenue=+1.2%